# Case-001 Public Share Kit Gate

Date checked: 2026-05-08
Evidence label: operational public-share gate, not medical advice

## Direct Answer

The next practical blocker is not a new treatment claim. It is a public share
kit that lets Nakafa Lab ask for help without exposing private records, creating
public medical advice, or making a cure claim.

Case-001 should use this public-safe operational label:

`public_share_kit_ready`

## Allowed Share States

- `draft_ready`;
- `public_post_ready`;
- `public_post_shared`;
- `inquiry_intake_needed`;
- `private_intro_needed`;
- `release_blocked`;
- `blocked_raw_record_request`;
- `blocked_treatment_advice`.

## Public Role Asks

| Needed role | Public-safe ask |
| --- | --- |
| Hematology or thalassemia clinician | Identify clinical labels and missing-record domains for qualified review. |
| Transfusion medicine or blood-bank reviewer | Review transfusion-burden and immune/blood-bank record needs. |
| Molecular genetics or genetic counseling reviewer | Review molecular or family-testing records needed before subtype claims. |
| Iron, MRI, cardiology, endocrine, or organ reviewer | Review iron and organ-risk packet completeness. |
| Transplant, gene-cell therapy, or trial-access reviewer | Explain screening pathways and access blockers without deciding eligibility publicly. |
| Wet-lab or assay partner | Review assay feasibility, readouts, controls, and quote requirements. |
| Software, reproducibility, privacy, funding, access, or Islamic ethics reviewer | Improve bounded tooling, access, or ethics work without private records or biomedical claims. |

## Plain-Language Shareable Finding

The useful discovery is a workflow discovery, not a cure:

> A transfusion-dependent thalassemia case cannot be reviewed as one broad
> question. It has to be split into diagnosis and genetics, transfusion burden,
> immune and blood-bank records, iron and organ monitoring, advanced-therapy
> screening, assay feasibility, privacy, and access. Each lane needs the right
> kind of expert.

## Public Post Rules

Use public posts only to request role-bounded help.

Do not post raw lab reports, screenshots, doctor messages, names, exact dates,
hospital names, clinician names, phone numbers, accession numbers, local paths,
private timelines, case-specific treatment instructions, or cure claims.

## Why This Matters

TIF 2025 separates transfusion-dependent thalassemia work into specialist
domains including diagnosis, blood transfusion, iron overload, monitoring, HCT,
and gene manipulation. GeneReviews separates phenotype labels from molecular
confirmation and genetic counseling. ClinicalTrials.gov records can help map
screening and access context, but registry presence is not case eligibility.
HHS de-identification guidance treats medical records and laboratory reports
with identifiers as protected health information and describes de-identification
as a risk-reduction process.

## Stop Conditions

Stop or downgrade public sharing when a draft asks strangers to make treatment
decisions, includes raw records or identifiers, implies a cure was found, or
cannot route a role claim to a bounded task.

## Biomedical Boundary

This gate does not diagnose, dose, change transfusion, change chelation,
recommend supplements, select a curative therapy, or decide trial eligibility.

## Islamic Motivation Boundary

Quran 5:2 is used as a cooperation-in-goodness anchor. Quran 16:43 is used as
an expert-consultation anchor. Quran 55:7-9 is used as a measurement and
anti-exaggeration anchor. These are method boundaries, not biomedical evidence.

## Sources

- [Case-001 public collaborator intake](../case-context/case-001-public-collaborator-intake.md)
- [Case-001 public share kit](../case-context/case-001-public-share-kit.md)
- [Public collaboration call template](../../../templates/public-collaboration-call-template.md)
- [HHS de-identification guidance](https://www.hhs.gov/hipaa/for-professionals/privacy/special-topics/de-identification/index.html)
- [TIF 2025 TDT guideline](https://www.ncbi.nlm.nih.gov/books/NBK614251/)
- [TIF 2025 blood transfusion chapter](https://www.ncbi.nlm.nih.gov/books/NBK614240/)
- [TIF 2025 iron overload chapter](https://www.ncbi.nlm.nih.gov/books/NBK614244/)
- [TIF 2025 gene manipulation chapter](https://www.ncbi.nlm.nih.gov/books/NBK614241/)
- [GeneReviews beta-thalassemia](https://www.ncbi.nlm.nih.gov/books/NBK1426/)
- [ClinicalTrials.gov thalassemia search](https://clinicaltrials.gov/search?cond=Thalassemia)
- [Quran 5:2 cooperation anchor](../../islamic/quran/005-al-maidah/002.md)
- [Quran 16:43 expert-consultation anchor](../../islamic/quran/016-an-nahl/043.md)
- [Quran 55:7-9 mizan anchor](../../islamic/quran/055-ar-rahman/007-009.md)
